IP Library Granted Patent US 9,821,066
Granted Patent B2
US 9,821,066 · App. 13/841,297 · Granted Nov 21, 2017

Tinted antiseptic solutions having improved stability

Inventors: Kenneth M. Dokken (El Paso, TX); Tenoch Benitez (El Paso, TX); James Bardwell (Downingtown, PA)
Assignee: Carefusion 2200, Inc.
A61K47/32A61B46/40A61K31/155A61K31/444A61L26/0014A61L26/0066A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,821,066
App. No.
13/841,297
Granted
Nov 21, 2017
Kind
B2
Abstract

An antiseptic solution including, a cationic antiseptic agent, a film forming polymer, an anionic tinting agent, and a solvent, wherein the cationic antiseptic agent, the film forming polymer and the anionic tinting agent each remain solubilized within the solution for greater than about 1 hour at 25° C. and 60% relative humidity. The antiseptic agent is preferably octenidine dihydrochloride or chlorhexadine gluconate. The film forming polymer is preferably an acrylate polymer. The solvent is preferably ethanol, isopropanol, and n-propanol. When a drape is adhered to a dried surgical film via the antiseptic solution, the force required to peel the drape from the surgical film is at least about 105 g/25 mm.

Claims (28)

1. An antiseptic solution comprising:

about 0.0001% w/v to about 2.0% w/v of a cationic antiseptic agent, wherein the cationic antiseptic agent comprises a cationic surfactant and one selected from the group consisting of a biguanide or a bis-(dihydropyridinyl)-decane derivative;

about 0.1% w/v to about 5% w/v of a film forming polymer comprising an acrylate polymer;

about 0.01% to about 0.15% w/v of an anionic tinting agent; and

a solvent,

wherein the polymer is selected from the group consisting of 2-propenoic acid, 2-methyl-, polymer with butyl 2-propenoate and methyl 2-methyl-2-propenoate and 2-propenoic acid, 2-methyl-, 2-methylpropyl ester, polymer with 2-propenoic acid and N-(1,1,3,3tetramethylbutyl)-2-propenamide, and

the cationic antiseptic agent, the film forming polymer, and the anionic tinting agent each remain solubilized within the solution for about 1 hour or more at 25° C. and 60% relative humidity.

2. The antiseptic solution of claim 1 , wherein the cationic antiseptic agent, the film forming polymer, and the anionic tinting agent each remain solubilized for about 24 hours or more at 25° C. and 60% relative humidity.

3. The antiseptic solution of claim 1 , wherein the cationic antiseptic agent, the film forming polymer, and the anionic tinting agent each remain solubilized for about 1 month or more at 25° C. and 60% relative humidity.

4. The antiseptic solution of claim 1 , wherein the cationic antiseptic agent, the film forming polymer, and the anionic tinting agent each remain solubilized for at 3 month or more at 25° C. and 60% relative humidity.

5. The antiseptic solution of claim 1 , wherein the antiseptic agent comprises an octenidine salt or chlorhexadine salt.

6. The antiseptic solution of claim 1 , wherein the antiseptic agent comprises octenidine dihydrochloride or clorhexadine gluconate.

7. The antiseptic solution of claim 1 , wherein the anionic tinting agent comprises an agent selected from the group consisting of Blue No. 1, Blue No. 2, Green No. 3, Red No. 3, Red No. 40, Yellow No. 5, Yellow No. 6, Yellow No. 8, Orange No. 4, and combinations thereof.

8. The antiseptic solution of claim 1 , wherein the solvent comprises an alcoholic solvent.

9. The antiseptic solution of claim 8 , wherein the solvent comprises an alcoholic solvent selected from the group consisting of ethanol, isopropanol, and n-propanol.

10. The antiseptic solution of claim 8 , wherein the concentration of the solvent is about 50 to about 80% v/v.

11. The antiseptic solution of claim 1 , further comprising a plasticizer.

12. The antiseptic solution of claim 11 , wherein the plasticizer comprises triethyl citrate or dibutyl sebacate.

13. The antiseptic solution of claim 11 , wherein the concentration of the plasticizer is about 0.05% to about 2% w/v.

14. A method of disinfecting a surface comprising applying the antiseptic solution of claim 1 to the surface.

15. The method of claim 14 , wherein the surface is human skin.

16. A method of adhering a drape to a surface, the method comprising:

applying the antiseptic solution of claim 1 to the surface;

allowing the antiseptic solution to dry, thereby producing a tacky film; and

contacting the drape with the tacky film such that the drape is adhered to the surface via the tacky film.

17. The method of claim 16 , wherein the surface is human skin.

18. The method of claim 16 , wherein the force required to peel the drape from the surface is about 105 g/25 mm or more.

19. An antiseptic applicator comprising the antiseptic solution of claim 1 contained therein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2015
From: DOKKEN, KENNETH M; BENITEZ, TENOCH; BARDWELL, JAMES
To: CAREFUSION 2200, INC.
Reel/Frame 036751/0686 →
Continuity (1)
Related Publication 20140261454A1 · Sep 18, 2014